Infect Control Hosp Epidemiol by Anderson, Deverick J. et al.
Decontamination of Targeted Pathogens from Patient Rooms 
Using an Automated Ultraviolet-C-Emitting Device
Deverick J. Anderson, MD, MPH1,2, Maria F. Gergen, MT (ASCP)3, Emily Smathers, MPH2, 
Daniel J. Sexton, MD1,2, Luke F. Chen, MBBS, MPH1,2, David J. Weber, MD, MPH3,4, William 
A. Rutala, PhD, MPH3,4, and CDC Prevention Epicenters Program
1Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, 
Durham, North Carolina
2Duke Infection Control Outreach Network, Duke University Medical Center, Durham, North 
Carolina
3Department of Hospital Epidemiology, University of North Carolina Health Care, Chapel Hill, 
North Carolina
4Division of Infectious Diseases, Department of Medicine, University of North Carolina School of 
Medicine, Chapel Hill, North Carolina
Abstract
OBJECTIVE—To determine the effectiveness of an automated ultraviolet-C (UV-C) emitter 
against vancomycin-resistant enterococci (VRE), Clostridium difficile, and Acinetobacter spp. in 
patient rooms.
DESIGN—Prospective cohort study.
SETTING—Two tertiary care hospitals.
PARTICIPANTS—Convenience sample of 39 patient rooms from which a patient infected or 
colonized with 1 of the 3 targeted pathogens had been discharged.
INTERVENTION—Environmental sites were cultured before and after use of an automated UV-
C-emitting device in targeted rooms but before standard terminal room disinfection by 
environmental services.
RESULTS—In total, 142 samples were obtained from 27 rooms of patients who were colonized 
or infected with VRE, 77 samples were obtained from 10 rooms of patients with C. difficile 
infection, and 10 samples were obtained from 2 rooms of patients with infections due to 
Acinetobacter. Use of an automated UV-C-emitting device led to a significant decrease in the total 
number of colony-forming units (CFUs) of any type of organism (1.07 log10 reduction; P < .
0001), CFUs of target pathogens (1.35 log10 reduction; P < .0001), VRE CFUs (1.68 log10 
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reduction; P < .0001), and C. difficile CFUs (1.16 log10 reduction; P < .0001). CFUs of 
Acinetobacter also decreased (1.71 log10 reduction), but the trend was not statistically significant 
(P = .25). CFUs were reduced at all 9 of the environmental sites tested. Reductions similarly 
occurred in direct and indirect line of sight.
CONCLUSIONS—Our data confirm that automated UV-C-emitting devices can decrease the 
bioburden of important pathogens in real-world settings such as hospital rooms.
The hospital environment is receiving increasing attention as a source for acquisition and 
spread of pathogens among hospitalized patients. In particular, 4 key organisms appear to 
survive in the environment long enough to place patients at risk. Vegetative bacteria such as 
methicillin-resistant Staphylococcus aureus (MRSA),1,2 vancomycin-resistant enterococci 
(VRE),3 and Acinetobacter spp.4–6 may persist on environmental surfaces for days or weeks. 
Clostridium difficile spores can persist on environmental surfaces for up to 5 months.7 In 
fact, acquisition of these organisms from the environment has previously been demonstrated, 
particularly when a patient is admitted to a room from which a patient colonized or infected 
with these important pathogens was just discharged.8–11
Standard approaches to environmental cleaning are inadequate.12–14 As a result, new, 
automated technologies are being investigated to determine how best to enhance terminal 
room disinfection of the hospital environment. One such technology is ultraviolet (UV) 
radiation. UV-C light near a wavelength of 254 nm induces the formation of pyrimidine 
dimers from thymine and cytosine.15 These dimers in turn cause breaks in microbial DNA 
that make genetic replication impossible, thus destroying the organisms or rendering them 
unable to grow or reproduce.16
The evidence that automated UV-C emitters can enhance disinfection of the hospital 
environment is growing. To date, authors of previously published studies have demonstrated 
that UV-C can effectively eradicate MRSA, VRE, Acinetobacter, and C. difficile under 
experimental conditions.15–20 To our knowledge, however, only 2 studies have evaluated the 
effectiveness of automated UV-C emitters in real hospital environments.19,21 These studies 
confirmed that the automated UV-C emitter reduced the bioburden of MRSA, VRE, and C. 
difficile in clinical settings.19,21
The objective of this study was to add to this growing literature by (1) determining the 
effectiveness of an automated UV-C emitter against VRE and C. difficile in a multicenter 
clinical environment and (2) evaluating the effectiveness of this automated UV-C emitter 
against Acinetobacter spp. in real-world clinical settings.
METHODS
This study was performed at 2 tertiary acute care hospitals, Duke University Medical Center 
(753 beds) and the University of North Carolina Health Care (804 beds), from July 2011 
through September 2012. The study protocol was reviewed by institutional review board 
committees at both institutions and determined to be exempt.
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We performed an interventional study on a convenience sample of hospital rooms. Three 
pathogenic organisms were targeted: VRE, C. difficile, and Acinetobacter spp. Hospital 
rooms were identified using microbiological and infection control databases to search for 
patients placed on contact precautions as a result of colonization or infection with a target 
organism.
After a targeted room was identified, environmental cultures were obtained after patient 
discharge but before standard terminal room disinfection by environmental services 
personnel. A minimum of 5 environmental sites were cultured in triplicate from each room, 
using Rodac plates. The 5 environmental sites targeted for culture included the bedside rail, 
bedside table, chair arm, overbed table, and sink counter. When one of these surfaces was 
not available, supply carts were cultured. The toilet, shower floor, and floor adjacent to the 
toilet were also cultured in targeted rooms from which a patient with C. difficile infection 
was just discharged. Each environmental culture site was assessed and recorded as in either 
direct or indirect line of sight of the automated UV-C-light-emitting device. The automated 
UV-C-emitting device was then used in the room. Environmental cultures were repeated in 
triplicate from the same environmental sites, following application of UV-C light. Following 
these cultures, environmental services performed a standard terminal room disinfection per 
standard hospital protocol, and the room was made available for the next patient.
Automated UV-C-Emitting Device
Each institution had access to 1 automated UV-C-emitting device (Tru-D SmartUVC; 
Lumalier). The automated UV-C device emits light at a wavelength of 254 nm and measures 
the reflected dose of light, using 8 sensors mounted on the device. Each device was 
programmed to deliver a reflected dose of 12,000 μWs/cm2 for vegetative bacteria (VRE or 
Acinetobacter) or 22,000 μWs/cm2 for spores (C. difficile). The device was operated by 
trained study personnel. The device was rolled into the targeted room and placed 
approximately in the center of the room. Care was taken to ensure that drawers and cabinets 
were opened before using the machine. In particular, the UV-C device was placed in a 
location to ensure that light was emitted into the room’s bathroom whenever possible. The 
time required for the device to deliver the above minimum reflected doses was measured.
Microbiological Methods
Dey/Engley (D/E) Neutralizing Agar or Clostridium difficile Selective Agar was used in the 
Rodac plates. All plates were incubated at 37°C for 48 hours; all C. difficile plates were 
incubated anaerobically. For patient rooms targeted for vegetative bacteria, 2 quantitative 
microbiologic outcomes were determined: the total number of colony-forming units (CFUs) 
of any organism present on each plate and the total number of CFUs of the targeted 
pathogen present on each plate. For C. difficile, only the total number of CFUs of the 
targeted pathogen present on each plate was determined. In either scenario, the number of 
targeted pathogens was quantified by first identifying morphologies suggestive of the target 
organisms. These colonies were then subcultured and identified using standard 
microbiological methods.
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Standard descriptive statistics were used, including medians and interquartile ranges (IQRs) 
for non-normally distributed continuous variables. The Wilcoxon signed rank sums test was 
used to determine differences between the number of CFUs before and after use of the UV-
C device. For these analyses, quantitative results from triplicate cultures were aggregated so 
that the comparison unit for statistical comparison was the number of CFUs per 
environmental site, not per plate. The McNemar test was used to determine differences 
between the proportions of positive plates before and after use of the UV-C device.
RESULTS
We sampled 229 environmental surfaces from the rooms of 39 patients during the 15-month 
study period. In total, 142 samples were obtained from 27 rooms of patients who were 
colonized or infected with VRE, 77 samples were obtained from 10 rooms of patients with 
C. difficile infection, and 10 samples were obtained from 2 rooms of patients with infections 
due to Acinetobacter. The median time for the UV-C vegetative cycle to be completed was 
25 minutes (IQR, 20–35); the median time for the UV-C spore cycle to be completed was 45 
minutes (IQR, 42–61).
The total number of CFUs of any type of pathogen detected on culture plates from all 
sampled environmental sites decreased from 28,642 to 2,444 following use of the UV-C 
device (1.07 log10 reduction; Table 1). The median number of CFUs per sample decreased 
from 110 (IQR, 49–251) to 4 (IQR, 1–11) following use of the UV-C device (P < .0001). 
Similarly, the total number of CFUs of target organisms from all cultured environmental 
sites decreased from 1,488 to 66 following use of the UV-C device (1.35 log10 reduction; P 
< .0001). A greater than 1 log10 overall reduction was achieved for all 3 target organisms 
following use of the UV-C device. VRE CFUs decreased from 712 to 15 following use of 
the UV-C device (1.68 log10 reduction; P < .0001), C. difficile CFUs decreased from 724 to 
51 (1.16 log10 reduction; P < .0001), and Acinetobacter decreased from 52 to 1 (1.71 log10 
reduction; P = .25; Table 1).
A greater than 1 log10 reduction was observed in cultures obtained from sites in both direct 
and indirect line of site for total CFUs of any organism, total CFUs of the 3 targeted 
organisms, VRE CFUs, and Acinetobacter CFUs (Table 1). A 0.80 log10 reduction was 
observed for C. difficile in direct line of sight, but a 1.18 log10 reduction was observed in 
indirect line of sight. No statistically significant differences were observed in the reductions 
that occurred in direct versus indirect line of sight disinfection for any of these categories.
The total number of CFUs was reduced following use of UV-C light at each of the 9 
environmental locations tested for total CFUs of any organism and each of the 3 targeted 
organism (Table 2); the greatest reduction was observed on the overbed table (98%), while 
the lowest reduction was observed on the bathroom floor adjacent to the toilet (74%). VRE 
was identified on 49 (11%) of 428 plates before use of the UV-C device and only 6 (1%) of 
428 plates afterward (P < .0001; Figure 1). The proportion of C. difficile–positive plates 
similarly decreased from 10% to 5% (P = .03). While the proportion of Acinetobacter-
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positive plates decreased from 13% to 3%, this trend was not statistically significant (P = .
38).
DISCUSSION
Numerous studies have demonstrated that current strategies for terminal room disinfection 
are inadequate. In fact, 50% or more hospital surfaces may go untouched and uncleaned 
following terminal room disinfection.12 UV-C light is a novel method to enhance terminal 
disinfection of hospital rooms. Our multicenter, prospective study confirms that automated 
UV-C emitters substantially decrease the bioburden of important pathogens, such as VRE 
and C. difficile, from patient rooms in real-world settings. In addition, our data suggest that 
an automated UV-C emitter can help reduce the bio-burden of Acinetobacter spp. It was 
likely that the reduction in the bioburden of Acinetobacter spp. was not statistically 
significant because of the low frequency of Acinetobacter infection in our study hospitals.
Authors of several studies have investigated the efficacy of automated UV-C emitters 
against important pathogens in nonclinical, experimental conditions.15–17 For example, 
Boyce et al18 used a quantitative disk carrier method to evaluate the efficacy of UV-C light 
emitters in reducing the burden of C. difficile spores in patient rooms. Disks inoculated with 
105 to 106 nontoxigenic C. difficile spores were placed in specific locations in 25 patient 
rooms and then exposed to light from an automated UV-C-emitting device. C. difficile 
spores were reduced between 1.4 and 2.9 log10.18
To our knowledge, however, only 2 previously published studies have evaluated the 
effectiveness of automated UV-C emitters in clinical conditions following patient discharge. 
Rutala et al19 cultured 10 targeted environmental surfaces in 8 rooms of patients previously 
placed in contact precautions because of colonization or infection with MRSA. An 
automated UV-C-emitting device was used before cleaning. UV-C irradiation led to 
decreases in total CFUs per culture plate, in the number of samples positive of MRSA, and 
in MRSA counts per plate.19 Nerandzic et al21 performed a similar experiment in 66 rooms 
of patients previously placed in contact precautions for MRSA or C. difficile. The proportion 
of sites positive for MRSA or C. difficile significantly decreased following UV-C 
irradiation. While the proportion of surfaces positive for VRE decreased from 2.7% to 0.4%, 
this trend was not statistically significant (P = .07).21
Our multicenter study utilized similar methods and confirmed that application of measured 
doses of UV-C light produced greater than 1 log10 reductions in the bioburden of C. difficile 
spores. These reductions also were observed from environmental sites in both direct and 
indirect line of sight locations relative to the portable UV-C-light-emitting device. Unlike 
the study by Nerandzic et al,21 we also targeted and sampled patient rooms from which a 
patient on contact precautions for VRE had been discharged. In this setting, UV-C light led 
to a 1.68 log10 reduction in colony counts of VRE at sampled environmental sites.
We are not aware of prior studies that have evaluated the efficacy of automated UV-C 
emitters in reducing the environmental bioburden of Acinetobacter in clinical settings such 
as patient rooms. In our study, UV-C light led to a 1.71 log10 reduction in the environmental 
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bioburden of Acinetobacter. Similarly, the proportion of sampled locations positive for 
Acinetobacter decreased from 13% to 1%. Unfortunately, we were able to enroll only 2 
rooms for Acinetobacter that met enrollment criteria during our study. Thus, our analysis 
was statistically underpowered.
Our results and the results cited above demonstrate that UV-C is less effective at killing 
bacteria in clinical settings compared with experimental, nonclinical conditions. For 
example, the application of UV-C light via automated devices has been shown to decrease 
the bioburden of MRSA, VRE, C. difficile, and Acinetobacter by 3–4 log10 in experimental 
conditions (eg, inoculated formica sheets or discs).19 In contrast, the use of an automated 
UV-C light emitter produced a 1.07 log10 reduction in total CFUs and a 1.35 log10 reduction 
in targeted pathogens in our study. Because cultures were obtained before and after 
application of UV-C light in rooms that had not undergone standard cleaning and 
disinfection, it is possible that the efficacy of UV-C was adversely affected by the presence 
of dirt and debris on surfaces and equipment. For example, the authors of a recent study of 
the efficacy of hand-held UV-C devices reported that these devices were ineffective for the 
disinfection of 72% of the 68 computer keyboards located in hospital wards if mechanical 
cleaning was not performed before attempted disinfection with UV-C light.22 In another 
study, UV-C was effective in disinfecting ultrasound probes only if it was applied after 
surfaces were disinfected with mechanical friction and a chemical disinfectant.23 Nerandzic 
et al21 previously investigated the effectiveness of an automated UV-C emitter following 
cleaning by environmental staff. No samples from 26 rooms were contaminated with MRSA 
following both terminal room disinfection and use of the automated UV-C emitter.21 These 
studies and our results suggest that UV-C disinfection may be more effective when used 
after traditional cleaning protocols. Thus, cleaning must remain an important part of 
terminal room disinfection, but in its absence or on locations missed by cleaning staff, more 
than 90% of pathogenic bacteria will still be killed when an automated UV-C device is used.
Our study has limitations. First, we utilized a convenience sample of patient rooms from 2 
acute care tertiary care hospitals. Thus, our data may not be generalizable to other settings. 
Second, the minority of our samples identified pathogens of interest. While this may have 
limited some of our statistical power, our findings are actually consistent with other 
published studies. That is, in general, approximately 10%–20% of surfaces are typically 
contaminated with pathogenic bacteria.19,21 Third, we were able to study only 2 rooms of 
patients infected with Acinetobacter spp., thus limiting the statistical power of our results. 
Finally, our study did not provide any patient-specific information, thereby limiting our 
ability to make conclusions about the impact of this technology for specific patient groups 
(eg, immunocompromised patients).
The use of UV-C radiation in medical settings is expanding to novel settings and through 
novel methods. For example, UV-C has recently been used to decontaminate specific rooms 
in long-term care facilities24 and has been trialed with hand-held devices.22,25 Our data 
support and expand on previously published studies to confirm that automated UV-C-
emitting devices can decrease the bioburden of important pathogens in hospital rooms. 
Whether this method actually leads to improved patient safety, decreased acquisition of 
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pathogenic bacteria, and decreased rates of health care–associated infections remains to be 
seen.
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Change in proportion of positive plates for target organisms before and after use of an 
automated ultraviolet-C emitter.
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